References
Caballero T, Baeza ML, Cabañas R, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol. 2011;21(5):333–347; quiz follow 347.
Craig TJ, Aygören-Pürsün E, Bork K, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J. 2012;5(12):182–99. doi:10.1097/WOX.0b013e318279affa.
Nielsen EW, Johansen HT, Holt J, Mollnes TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res. 1994;35(2):184–7. doi:10.1203/00006450-199402000-00012.
Grumach AS, Ceccon ME, Rutz R, Fertig A, Kirschfink M. Complement profile in neonates of different gestational ages. Scan J Immunol. 2014;79(4):276–81. doi:10.1111/sji.12154.
Roche O, Blanch A, Duponchel C, et al. Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large spanish cohort. Hum Mutat. 2005;26(2):135–44. doi:10.1002/humu.20197.
López-Lera A, Garrido S, Roche O, López-Trascasa M. SERPING1 mutations in 59 families with hereditary angioedema. Mol Immunol. 2011;49(1–2):18–27. doi:10.1016/j.molimm.2011.07.010.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. María Pedrosa has received speaker fees from Shire, sponsorship for educational purposes and has taken part in clinical trials sponsored by Jerini AG/Shire, CSL-Behring, and Pharming NV.
Dr. Elsa Phillips-Angles has received sponsorship for educational purposes and has taken part in clinical trials sponsored by Shire and CSL-Behring.
Dr. Alberto López-Lera has received sponsorship for educational purposes sponsored by Jerini AG/Shire.
Dr. Margarita López Trascasa has received sponsorship for educational purposes sponsored by Jerini AG/Shire.
Dr. Teresa Caballero has received speaker fees from Shire and ViroPharma, consultancy fees from CSL Behring, Shire, SOBI and ViroPharma, and funding for travel and meeting attendance from CSL Behring and Shire; and has participated in clinical trials or registries for CSL Behring, Dyax, Pharming, Shire and ViroPharma.
Funding
This study was funded by a grant awarded by the Spanish Ministry of Health (SAF 2012/38636)
Rights and permissions
About this article
Cite this article
Pedrosa, M., Phillips-Angles, E., López-Lera, A. et al. Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children. J Clin Immunol 36, 16–18 (2016). https://doi.org/10.1007/s10875-015-0222-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-015-0222-9